Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
- PMID: 29636618
- PMCID: PMC5881528
- DOI: 10.2147/TCRM.S162690
Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
Abstract
Purpose: Oxidative stress has been implicated in several disorders, including acute pancreatitis (AP). Ischemia-modified albumin (IMA), which reflects the ability to bind cobalt, has been found to be elevated in conditions of oxidative stress and tissue hypoxia. This study examined IMA and adjusted IMA levels in patients with AP, and examined the associations of IMA and adjusted IMA levels to the severity of AP.
Patients and methods: A total of 42 consecutive patients with AP and 43 age- and sex-matched control subjects were enrolled. Serum samples were obtained from patients with AP on admission as well as 48-72 hours after hospitalization, and from the controls, at the time of enrollment. Adjusted IMA was calculated by multiplying the IMA value of each patient with the ratio of the patient's albumin value and the median albumin value of the study population. The severity of AP was assessed according to the modified Atlanta classification, and the patients were divided into 2 groups: mild AP and severe AP.
Results: The serum IMA and adjusted IMA values of patients with AP on admission and those of the controls did not differ (p=0.86 and p=0.99, respectively). The second measurements of IMA and adjusted IMA in the AP group were higher than the first measurements of both the AP group and controls (for all, p<0.01). Among the IMA measurements, only adjusted IMA on admission had the ability to predict the severity of AP. Severe AP was correlated with albumin, and the area under the curve of adjusted IMA values on admission was 0.746 for differentiating patients with severe AP from mild AP with statistical significance (p=0.005).
Conclusion: It was shown that IMA and adjusted IMA levels rise with the progression of AP. Lower levels of adjusted IMA predict the severity of AP. Further studies with serial measurements of IMA are warranted to explore the indicative role of IMA in the course of AP.
Keywords: acute pancreatitis; adjusted ischemia modified albumin; ischemia modified albumin; severity.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures


Similar articles
-
Can Ischemia Modified Albumin (IMA) Levels Be a Predictor of Acute Pancreatitis?Turk J Gastroenterol. 2021 Mar;32(3):327-335. doi: 10.5152/tjg.2021.191054. Turk J Gastroenterol. 2021. PMID: 34160363 Free PMC article.
-
Evaluation of the relationship between adjusted ischemia-modified albumin and the presence and severity of peripheral artery disease.Vascular. 2024 Jun;32(3):603-611. doi: 10.1177/17085381221141473. Epub 2022 Nov 27. Vascular. 2024. PMID: 36437682
-
Correlation between ischemia-modified albumin and Ranson score in acute pancreatitis.Ulus Travma Acil Cerrahi Derg. 2017 Nov;23(6):472-476. doi: 10.5505/tjtes.2017.51499. Ulus Travma Acil Cerrahi Derg. 2017. PMID: 29115648
-
Role of Ischemia Modified Albumin Serum Levels as an Oxidative Stress Marker in Children with Diabetic Ketoacidosis.Comb Chem High Throughput Screen. 2019;22(8):577-581. doi: 10.2174/1386207322666191008214919. Comb Chem High Throughput Screen. 2019. PMID: 31595845 Clinical Trial.
-
SIGNIFICANCE OF ISCHEMIA-MODIFIED ALBUMIN AS A SIMPLE MEASURE OF OXIDATIVE STRESS AND ITS DISCRIMINATORY ABILITY IN DIABETIC RETINOPATHY: Literature Review and Meta-Analysis.Retina. 2016 Jun;36(6):1049-57. doi: 10.1097/IAE.0000000000001042. Retina. 2016. PMID: 27105326 Review.
Cited by
-
Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome.Metabolomics. 2025 May 21;21(3):70. doi: 10.1007/s11306-025-02264-w. Metabolomics. 2025. PMID: 40399692 Free PMC article.
-
[The effect of low dose ionizing radiation exposure on dynamic thiol-disulfide homeostasis and ischemia modified albumin levels: an observational study].Braz J Anesthesiol. 2020 May-Jun;70(3):233-239. doi: 10.1016/j.bjan.2020.02.009. Epub 2020 May 13. Braz J Anesthesiol. 2020. PMID: 32482354 Free PMC article.
-
A Comparative Study of Ischemia-Modified Albumin: A Promising Biomarker for Early Detection of Acute Coronary Syndrome (ACS).Cureus. 2023 Aug 30;15(8):e44357. doi: 10.7759/cureus.44357. eCollection 2023 Aug. Cureus. 2023. PMID: 37779796 Free PMC article.
-
Can Ischemia Modified Albumin (IMA) Levels Be a Predictor of Acute Pancreatitis?Turk J Gastroenterol. 2021 Mar;32(3):327-335. doi: 10.5152/tjg.2021.191054. Turk J Gastroenterol. 2021. PMID: 34160363 Free PMC article.
References
-
- Banks PA, Bollen TL, Dervenis C, et al. Acute Pancreatitis Classification Working Group Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. - PubMed
-
- Chen Y, Zak Y, Hernandez-Boussard T, Park W, Visser BC. The epidemiology of idiopathic acute pancreatitis, analysis of the nationwide inpatient sample from 1998 to 2007. Pancreas. 2013;42(1):1–5. - PubMed
-
- Schutte K, Malfertheiner P. Markers for predicting severity and progression of acute pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22(1):75–90. - PubMed
-
- Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52(6):273–283. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources